A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation. Issue 1 (October 2017) - Takeichi, Takuya; Tsukamoto, Katsuhiko; Okuno, Yusuke; Kojima, Daiei; Kono, Michihiro; Suga, Yasushi; Akiyama, Masashi